Wynne, C., Schwabe, C., Vincent, E., Schueler, A., Ryding, J., Ullmann, M., . . . Stahl, M. (2020). Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta(®) in healthy subjects: A randomized, double‐blind trial. Pharmacol Res Perspect.
Citação norma ChicagoWynne, Chris, Christian Schwabe, Emmanuelle Vincent, Armin Schueler, Janka Ryding, Martin Ullmann, Vishal Ghori, Radmila Kanceva, and Michael Stahl. "Immunogenicity and Safety of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta(®) in Healthy Subjects: A Randomized, Double‐blind Trial." Pharmacol Res Perspect 2020.
MLA CitationWynne, Chris, et al. "Immunogenicity and Safety of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta(®) in Healthy Subjects: A Randomized, Double‐blind Trial." Pharmacol Res Perspect 2020.